KR20230136643A - Al 아밀로이드증 치료 방법 - Google Patents

Al 아밀로이드증 치료 방법 Download PDF

Info

Publication number
KR20230136643A
KR20230136643A KR1020237029277A KR20237029277A KR20230136643A KR 20230136643 A KR20230136643 A KR 20230136643A KR 1020237029277 A KR1020237029277 A KR 1020237029277A KR 20237029277 A KR20237029277 A KR 20237029277A KR 20230136643 A KR20230136643 A KR 20230136643A
Authority
KR
South Korea
Prior art keywords
patient
meters
treatment
amyloidosis
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237029277A
Other languages
English (en)
Korean (ko)
Inventor
진 키니
와그너 자고
라디카 트리푸라네니
캐롤 카프
Original Assignee
프로테나 바이오사이언시즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로테나 바이오사이언시즈 리미티드 filed Critical 프로테나 바이오사이언시즈 리미티드
Publication of KR20230136643A publication Critical patent/KR20230136643A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
KR1020237029277A 2021-01-29 2022-01-29 Al 아밀로이드증 치료 방법 Pending KR20230136643A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
US63/143,728 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
KR20230136643A true KR20230136643A (ko) 2023-09-26

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237029277A Pending KR20230136643A (ko) 2021-01-29 2022-01-29 Al 아밀로이드증 치료 방법

Country Status (13)

Country Link
US (1) US20250084153A1 (cg-RX-API-DMAC7.html)
EP (1) EP4284829A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024505923A (cg-RX-API-DMAC7.html)
KR (1) KR20230136643A (cg-RX-API-DMAC7.html)
CN (1) CN117098775A (cg-RX-API-DMAC7.html)
AU (1) AU2022213010A1 (cg-RX-API-DMAC7.html)
CA (1) CA3206326A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002236A1 (cg-RX-API-DMAC7.html)
IL (1) IL304755A (cg-RX-API-DMAC7.html)
JO (1) JOP20230172A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023008835A (cg-RX-API-DMAC7.html)
TW (1) TW202332465A (cg-RX-API-DMAC7.html)
WO (1) WO2022162625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55209A (fr) 2019-03-05 2022-01-12 Prothena Biosciences Ltd Procédés de traitement de l'amylose al

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63446B1 (sr) * 2016-06-30 2022-08-31 Prothena Biosciences Ltd Kompozicije za lečenje amiloidoze
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
MA55209A (fr) * 2019-03-05 2022-01-12 Prothena Biosciences Ltd Procédés de traitement de l'amylose al

Also Published As

Publication number Publication date
AU2022213010A9 (en) 2024-09-26
IL304755A (en) 2023-09-01
AU2022213010A1 (en) 2023-08-17
EP4284829A1 (en) 2023-12-06
TW202332465A (zh) 2023-08-16
MX2023008835A (es) 2023-09-08
CL2023002236A1 (es) 2024-02-09
US20250084153A1 (en) 2025-03-13
JP2024505923A (ja) 2024-02-08
CA3206326A1 (en) 2022-08-04
JOP20230172A1 (ar) 2023-07-27
CN117098775A (zh) 2023-11-21
WO2022162625A1 (en) 2022-08-04

Similar Documents

Publication Publication Date Title
US12240894B2 (en) Methods of treating AL amyloidosis
JP2024127990A (ja) アミロイドーシスを処置するための組成物
US20250084153A1 (en) Methods of treating al amyloidosis
JP2024519450A (ja) 抗ガレクチン-9抗体及びその治療的使用
KR20240133743A (ko) Al 아밀로이드증 치료 방법
WO2025166118A1 (en) Dosage and administration of anti-c5 antibodies for treating iga nephropathy (igan)
KR20230009431A (ko) 발작성 야간 혈색소뇨증의 치료를 위한 보체 인자 d 저해제를 단독으로 또는 항-c5 항체와 조합한 용도
WO2025170969A1 (en) Methods of treating al amyloidosis
EA048260B1 (ru) Способы лечения al-амилоидоза
HK40066935B (en) An antibody for use in methods of treating al amyloidosis
HK40066935A (en) An antibody for use in methods of treating al amyloidosis

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230828

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250131

Comment text: Request for Examination of Application